Facebook-f Tiktok Instagram Youtube Whatsapp Linkedin

Doctor Profile

Back

Dr. Rui Feng

Vascular Surgery

Associate Professor · Chief Physician · Doctoral Supervisor · MD

Dr. Feng is the Director of the Interventional Training Base for Structural Heart Disease (Great Vessel Disease) at the Hospital Management Research Institute of the National Health Commission, and the Director of the Shanghai Clinical Database for Aortic Diseases. He serves as the Deputy Chairman of the Aortic Dissection Committee of the Chinese Medical Doctor Association, the Deputy Chairman of the Thoracic Aorta Committee of the Chinese Chapter of the International Union of Angiology, a Member of the International Society for Vascular Surgery, an Expert for Shanghai Medical Malpractice Appraisal, a Committee Member of the Vascular Surgery Branch of the Chinese Medical Doctor Association, and a Standing Committee Member of the Interventional Medicine Committee of the Chinese Research Hospital Association.

Vascular Surgery Expert

Aortic Diseases

Minimally Invasive Surgery

Complex Vascular Lesions

30+ yrs

Experience

400+/y

Surgeries

20+/y

Surgeries for patients over 90

Expertise

Specializes in minimally invasive treatments for aortic diseases, including aortic dissection and abdominal aortic aneurysm, is among the most experienced in complex aortic procedures both in China and abroad, pioneered techniques such as the multi-chimney and multi-fenestration methods, greatly improving outcomes for complex aortic arch and abdominal cases. Proficient in endovascular treatments for lower extremity arteriosclerosis, carotid and renal artery stenosis, splenic aneurysms, and venous thrombosis. In 2013, introduced China’s first minimally invasive techniques for renal aneurysms and AV fistulas.

Professional Background

Dr. Feng has been engaged in clinical work in vascular surgery for over 30 years, with a focus on endovascular interventional treatment of vascular diseases such as aortic dissection, abdominal aortic aneurysm, lower extremity arteriosclerosis obliterans, visceral aneurysms, carotid artery stenosis, and venous thrombosis. He is among the domestic surgeons with the largest number of cases and the highest difficulty in minimally invasive treatment of aortic diseases.

He has traveled to more than 200 large hospitals in 28 provinces across the country to guide the performance of complex aortic surgeries. He pioneered a series of innovative techniques internationally, including thoracoabdominal aortic double-trunk branched stent repair, abdominal aortic multi-fenestration technology, aortic arch multi-parallel stents, stepwise endovascular treatment of retrograde type A aortic dissection, and branched stent-assisted embolization of renal aneurysms.

With extensive experience in minimally invasive endovascular interventions for vascular diseases, he has made remarkable achievements in the diagnosis and treatment of complex vascular lesions, especially in promoting the application and innovation of minimally invasive techniques in aortic diseases.

Awards & Honors

  • Second Prize of National Science and Technology Progress Award
  • First prize of the Ministry of Education’s Science and Technology Progress Award
  • First Prize of Huaxia Medical Science and Technology Award
  • Huaxia Medical Science and Technology Popularization Award
  • First Prize for Military Medical Achievements

Recent Key Publications:

 

  1. Guo J, Yu C, Li H, Liu F, Feng R, Wang H, Meng Y, Li Z, Ju G, Wang J. Impaired neural stem/progenitor cell proliferation in streptozotocin-induced and spontaneous diabetic mice. Neurosci Res. 2010 Jul;68(3):329-336. doi: 10.1016/j.neures.2010.07.2065. PMID: 20670675.（IF=2.860）
  2. Wang H, Guo J, Zhao Y, Bian G, Liu F, Yu C, Feng R, Ju G, Wang J. Recovery of movement after spinal cord injury in DO11.10 transgenic mouse. Chin J Cell Mol Immunol. 2010 Mar;26(3):231-234. PMID: 20230685.
  3. Tang L, Yu C, Feng R, Liu F, Zhao Y, Guo H, Ju G, Wang J. Establishment of PD-L1 transgenic mouse model and recovery of the motion after spinal cord injury. Chin J Cell Mol Immunol. 2011;27(3):231-234. PMID: 21481304.
  4. Deng B, Liu F, Zhao X, Yu C, Bian G, Feng R, Ju G, Wang J. Identification of six kinds of monoclonal antibodies against rat Nogo-A molecule in the immunofluorescent histochemical staining. Chin J Cell Mol Immunol. 2011;27(3):231-234.
Book Appointment
Facebook-f Tiktok Instagram Youtube Whatsapp Linkedin

Doctor Profile

Dr. Rui Feng

Vascular Surgery
Associate Professor · Chief Physician · Doctoral Supervisor · MD

Vascular Surgery Expert
Aortic Diseases
Minimally Invasive Surgery
Complex Vascular Lesions
Dr. Rui Feng Vascular Surgery Associate Professor · Chief Physician · Doctoral Supervisor · MD Dr. Feng is the Director of the Interventional Training Base for Structural Heart Disease (Great Vessel Disease) at the Hospital Management Research Institute of the National Health Commission, and the Director of the Shanghai Clinical Database for Aortic Diseases. He serves as the Deputy Chairman of the Aortic Dissection Committee of the Chinese Medical Doctor Association, the Deputy Chairman of the Thoracic Aorta Committee of the Chinese Chapter of the International Union of Angiology, a Member of the International Society for Vascular Surgery, an Expert for Shanghai Medical Malpractice Appraisal, a Committee Member of the Vascular Surgery Branch of the Chinese Medical Doctor Association, and a Standing Committee Member of the Interventional Medicine Committee of the Chinese Research Hospital Association.

Experience

0 +yrs
0 +/y

Surgeries

0 +/y

Surgeries for patients over 90

Expertise

Specializes in minimally invasive treatments for aortic diseases, including aortic dissection and abdominal aortic aneurysm, is among the most experienced in complex aortic procedures both in China and abroad, pioneered techniques such as the multi-chimney and multi-fenestration methods, greatly improving outcomes for complex aortic arch and abdominal cases. Proficient in endovascular treatments for lower extremity arteriosclerosis, carotid and renal artery stenosis, splenic aneurysms, and venous thrombosis. In 2013, introduced China’s first minimally invasive techniques for renal aneurysms and AV fistulas.

Professional Background

 

Dr. Feng has been engaged in clinical work in vascular surgery for over 30 years, with a focus on endovascular interventional treatment of vascular diseases such as aortic dissection, abdominal aortic aneurysm, lower extremity arteriosclerosis obliterans, visceral aneurysms, carotid artery stenosis, and venous thrombosis. He is among the domestic surgeons with the largest number of cases and the highest difficulty in minimally invasive treatment of aortic diseases.

He has traveled to more than 200 large hospitals in 28 provinces across the country to guide the performance of complex aortic surgeries. He pioneered a series of innovative techniques internationally, including thoracoabdominal aortic double-trunk branched stent repair, abdominal aortic multi-fenestration technology, aortic arch multi-parallel stents, stepwise endovascular treatment of retrograde type A aortic dissection, and branched stent-assisted embolization of renal aneurysms.

With extensive experience in minimally invasive endovascular interventions for vascular diseases, he has made remarkable achievements in the diagnosis and treatment of complex vascular lesions, especially in promoting the application and innovation of minimally invasive techniques in aortic diseases.

 

SMA Treatment Cases

PART 1: Cases of Surgical Treatment For Severe Scoliosis

Female, 20 years old, severe spinal kyphoscoliosis with halo-pelvic traction

Correction rates: scoliosis 61.9% , kyphosis 40%

Blood transfusion: 300ml

Male, 27 years old, severe spinal kyphoscoliosis with halo-pelvic traction

Correction rates: scoliosis 22.5%, kyphosis 52.4%

Blood transfusion: 300ml

Female, 28 years old, severe spinal kyphoscoliosis with halo-pelvic traction

Correction rates: kyphosis 46.1%

Blood transfusion: 300ml

Female, 27 years old, severe spinal kyphoscoliosis with halo-pelvic traction

Correction rates: scoliosis 52.4%, kyphosis 50.0%

Blood transfusion: 600ml

PART 2: Cases of Surgical Treatment for Scoliosis Complicated with Rare Diseases

Indian patient, 13 years old, Stiff-Person Syndrome.
Post-op: scoliosis 38°, kyphosis 36°

Female, 22y

Weight 26.5kg

FVC=10.3%

FEV1=10.3%

Male, 21y

Type I SMA

Poor nutrition

FVC=14%

FEV1=14.3%

Female, 13y

Weight 23kg

Poor nutrition

PART 3: Cases of Surgical Treatment for Mild Scoliosis

Femael, 15 years old, Lenke 5 AIS, DVR correction LIV=L3, LIV≠L4 or L5

Male, 14 years old, Lenke 5 AIS, DVR correction LIV=L4, LIV≠L5

Female, 14 years old

LIV: CSVL+ (NT), Rot>II, Tilt>20°

Female, 16 years old

LIV: CSVL+ (NT), Rot>II, Tilt>25°

PART 4: Cases of Conservative Treatment for Scoliosis

Female, 12 yo, 2 years treatment, IBC 87.5%→133%,lumbar curve 40°→6° (cor rate 85%)

Male, 15 yo, 1.5 years treatment, IBC 117%→126%,thoraolumbar curve 42°→0° (cor rate 100%)

Female, 13 yo, 3 years treatment, IBC 50%→85%,

thoracic curve 40°→20° (cor rate 50%)

Female, 13 yo, 2y 3mons treatment, IBC 58.3%→81.3%,lumbar curve 48°→15° (cor rate 68.8%)

PART 4: Cases of Conservative Treatment for Scoliosis

Female, 12 yo, 2 years treatment, IBC 87.5%→133%,lumbar curve 40°→6° (cor rate 85%)

Male, 15 yo, 1.5 years treatment, IBC 117%→126%,thoraolumbar curve 42°→0° (cor rate 100%)

Female, 13 yo, 3 years treatment, IBC 50%→85%,

thoracic curve 40°→20° (cor rate 50%)

Female, 13 yo, 2y 3mons treatment, IBC 58.3%→81.3%,lumbar curve 48°→15° (cor rate 68.8%)

Case Videos

在此添加您的标题文本

在此添加您的标题文本

Awards & Honors

Second Prize of National Science and Technology Progress Award

First prize of the Ministry of Education’s Science and Technology Progress Award

First Prize of Huaxia Medical Science and Technology Award

Huaxia Medical Science and Technology Popularization Award

First Prize for Military Medical Achievements

Patient Reviews

[Anonymous] from Yunnan

2025-04-30

Rating:

Disease: Pediatric Congenital Scoliosis Description of Condition:
My child is six and a half years old, suffering from congenital hemivertebra at T10, with a scoliosis curvature of 25 degrees. Doctors in our hometown all recommended surgical treatment as soon as possible. We felt deeply distressed due to the child’s young age. Later, through a friend’s recommendation, we learned that Dr. Yang is a national expert in pediatric scoliosis. With a hopeful attitude, we came to Shanghai Xinhua Hospital.

Treatment Process:

First, we went to Dr. Yang’s assistant to check the quality of the imaging scans, confirming that re-scanning was unnecessary. Afterwards, we waited for Dr. Yang’s consultation. During this time, we encountered children from all over the country who had sought him out based on his reputation for scoliosis issues. It was 6:30 PM when it was finally our turn. Dr. Yang had already been consulting continuously for five hours. Yet, he patiently analyzed the child’s condition, earnestly answered our questions, determined that surgery was not necessary for the child, and taught the child postoperative rehabilitation exercises. The concept of “a healer’s benevolent heart” was embodied in this moment. We were deeply moved. Thank you, Dr. Yang!

Book Your Appointment